These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2231756)

  • 1. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.
    Pollak M; Costantino J; Polychronakos C; Blauer SA; Guyda H; Redmond C; Fisher B; Margolese R
    J Natl Cancer Inst; 1990 Nov; 82(21):1693-7. PubMed ID: 2231756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen reduces serum insulin-like growth factor I (IGF-I).
    Pollak MN; Huynh HT; Lefebvre SP
    Breast Cancer Res Treat; 1992; 22(1):91-100. PubMed ID: 1421427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer.
    Colletti RB; Roberts JD; Devlin JT; Copeland KC
    Cancer Res; 1989 Apr; 49(7):1882-4. PubMed ID: 2924327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer.
    Corsello SM; Rota CA; Putignano P; Della Casa S; Barnabei A; Migneco MG; Vangeli V; Barini A; Mandalà M; Barone C; Barbarino A
    Eur J Endocrinol; 1998 Sep; 139(3):309-13. PubMed ID: 9758441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients.
    Lønning PE; Hall K; Aakvaag A; Lien EA
    Cancer Res; 1992 Sep; 52(17):4719-23. PubMed ID: 1380889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
    Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.
    Grønbaek H; Tanos V; Meirow D; Peretz T; Raz I; Flyvbjerg A
    Anticancer Res; 2003; 23(3C):2815-20. PubMed ID: 12926118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
    Lien EA; Johannessen DC; Aakvaag A; Lønning PE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):541-3. PubMed ID: 1532904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women.
    Decensi A; Robertson C; Ballardini B; Paggi D; Guerrieri-Gonzaga A; Bonanni B; Manetti L; Johansson H; Barreca A; Bettega D; Costa A
    Eur J Cancer; 1999 Apr; 35(4):596-600. PubMed ID: 10492633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials.
    Li X; Hou X; Hernández-Wolters B; Prabahar K; Kord-Varkaneh H; Mei B
    Exp Gerontol; 2024 Jun; 191():112431. PubMed ID: 38608792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
    Birzniece V; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E521-7. PubMed ID: 22319035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.
    Birzniece V; Sata A; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5443-8. PubMed ID: 20843951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megestrol acetate may stimulate the production of insulin-like growth factor 1 in breast tissues of women with breast cancer.
    Fahlén M; Löfgren L; von Schoultz E; Naessén S; Carlström K; Söderqvist G
    Horm Mol Biol Clin Investig; 2013 Jun; 13(3):51-4. PubMed ID: 25436713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen.
    Howe SR; Pass HI; Ethier SP; Matthews WJ; Walker C
    Cancer Res; 1996 Sep; 56(17):4049-55. PubMed ID: 8752178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on GH and IGF-I levels in acromegaly.
    Cozzi R; Attanasio R; Oppizzi G; Orlandi P; Giustina A; Lodrini S; Da Re N; Dallabonzana D
    J Endocrinol Invest; 1997 Sep; 20(8):445-51. PubMed ID: 9364247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence.
    Metzger DL; Kerrigan JR
    J Clin Endocrinol Metab; 1994 Aug; 79(2):513-8. PubMed ID: 8045971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.